QA: Bellicum Pharmaceuticals INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2019_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 95,295,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 20,878,000
3 remainder_Assets 5,328,000
4 LiabilitiesCurrent 15,804,000
5 LiabilitiesNoncurrent 35,832,000
6 remainder_Liabilities 1,387,000
7 CostOfGoodsAndServicesSold 436,000
8 SellingGeneralAndAdministrativeExpense 28,163,190
9 ResearchAndDevelopmentExpense 77,834,415
10 remainder_Expenses 319,776
11 remainder_Revenues 185,000
12 remainder_NetIncome -2,801,553
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 121,501,000
1 Liabilities 53,023,000
2 Expenses 106,753,381
3 Revenues 185,000
4 StockholdersEquity 68,478,000
5 NetIncome -109,369,934
6 ComprehensiveNetIncome -109,369,934
7 BaseVar 142,131,967
8 EconomicCapitalRatiobeforeLimitedLiability 0.457
9 EconomicCapitalRatio 1.84

Edgar->Model Mapping

Feature Distribution

Change over Time